As Anaptysbio seeks to split off a royalty business, both companies claim the other breached contracts surrounding ...
Shares of AnaptysBio fell 14% in premarket trading on Friday after the U.S. drug developer and Tesaro, a unit of Britain's ...
GSK's Tesaro sues AnaptysBio over alleged Jemperli contract breaches, putting royalties, milestones, and future licensing ...
AnaptysBio (ANAB) shares lost ~11% in the premarket on Friday after the U.S. drugmaker and its partner Tesaro, a subsidiary ...
GSK is taking legal action against US biotech firm AnaptysBio, which it accuses of a 'material breach' of contractual ...
The litigation centers on Jemperli, a drug used to treat some forms of endometrial cancer. Anaptys originally discovered the drug and licensed it to Tesaro as part of a broader collaboration agreement ...
The companies accuse one another of breaching a licensing agreement for Jemperli, a drug used to treat some forms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback